Abstract
Summary
The global healthcare simulation market is projected to reach USD 5.2 billion by 2028 from USD 2.3 billion in 2023, at a high CAGR of 16.7% during the forecast period. The market's expansion is fueled by an increasing emphasis on patient safety and a preference for virtual interaction. Nevertheless, challenges such as a shortage of skilled healthcare professionals and the high cost of simulators are anticipated to somewhat impede the market's growth.
“The segment of web-based simulation demonstrated the most substantial growth in the healthcare simulation market, by product & service.”
In terms of product & service, the web-based simulation segment experienced the most significant growth in the healthcare simulation market throughout the forecast period. The expansion of this segment can be attributed to the widespread availability of internet services and the increasing government initiatives to adopt Healthcare Information Technology (HCIT) solutions.
“The largest segment in the healthcare simulation market by the end user was academic institutes in the year 2022.”
The academic institutes segment is anticipated to experience the highest growth rate in the healthcare simulation market in 2022. The rising use of simulation models in medical surgeries, a heightened emphasis on error reduction, and the cost-effectiveness of procedural training for medical physicians are expected to fuel the demand for healthcare simulation services in the upcoming years.
“APAC region is expected to experience the most substantial growth rate throughout the forecast period.”
The Asia-Pacific region is experiencing the highest growth rate in the healthcare simulation market due to several factors such as there is a rising awareness of the importance of advanced medical training and patient safety in healthcare across the region, increasing investments in healthcare infrastructure and education contribute to the adoption of simulation technologies and the growing demand for skilled healthcare professionals, coupled with advancements in technology, fuels the need for innovative training methods. The combination of these factors positions the region as a dynamic and rapidly expanding market for healthcare simulation solutions.
The break-down of primary participants is as mentioned below:
• By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
• By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%
Key Players in the Healthcare Simulation Market
The key players functioning in the healthcare simulation market include CAE (Canada), Laerdal Medical (Norway), Simulab Corporation (US), Simulaids (US), Limbs & Things (UK), Kyoto Kagaku (Japan), Mentice AB (Sweden), Gaumard Scientific Co. (US), Operative Experience Inc. (US), Cardionics Inc. (US) (a subsidiary of 3B Scientific), VirtaMed AG (Switzerland), SYNBONE AG (Switzerland), IngMar Medical (US), Medical-X (Netherlands), KaVo Dental GmbH (Germany), Altay Scientific (Italy), Simendo B.V. (Netherlands) VRMagic Holding AG (Germany), Symgery (Canada), HRV Simulation (France), Synaptive Medical (Canada), Inovus Medical (UK), TruCorp Ltd. (Ireland), and Surgical Science Sweden AG (Sweden).
Research Coverage:
The report analyses the healthcare simulation market. It aims to estimate the market size and future growth potential of various market segments based on product & service, end-user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms and new entrants/smaller firms to gauge the market's pulse, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
Analysis of key drivers: (Limited access to patients during medical training, Rising technological advancements in medical education), restraints (Increasing focus on patient safety, Growing preference for virtual interaction), opportunities (Growing awareness about simulation training in emerging economies), and challenges (High cost of simulators, Operational challenges) influencing the growth of the healthcare simulation market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare simulation market.
Market Development: Comprehensive information on the lucrative emerging markets, products & services, end-users, and regions.
Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare simulation market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare simulation market like CAE (Canada), Laerdal Medical (Norway), Simulab Corporation (US), Simulaids (US), Limbs & Things (UK).
Table of Contents
1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION AND SCOPE 40
1.2.1 INCLUSIONS AND EXCLUSIONS 40
1.2.2 MARKET SCOPE 41
1.2.3 REGIONAL SCOPE 42
1.2.4 YEARS CONSIDERED 42
1.3 CURRENCY CONSIDERED 43
1.4 UNITS CONSIDERED 43
1.5 STAKEHOLDERS 43
1.6 SUMMARY OF CHANGES 44
1.7 RECESSION IMPACT 44
2 RESEARCH METHODOLOGY 45
2.1 RESEARCH APPROACH 45
2.2 HEALTHCARE SIMULATION MARKET: RESEARCH DESIGN 45
2.2.1 SECONDARY RESEARCH 46
- 2.2.1.1 Key data from secondary sources 47
2.2.2 PRIMARY DATA 47
- 2.2.2.1 Key data from primary sources 48
- 2.2.2.2 Insights from primary experts 49
2.3 MARKET SIZE ESTIMATION: HEALTHCARE SIMULATION MARKET 50
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 55
2.5 MARKET SHARE ESTIMATION 56
2.6 RESEARCH ASSUMPTIONS 56
2.7 RESEARCH LIMITATIONS 57
2.7.1 METHODOLOGY-RELATED LIMITATIONS 57
2.7.2 SCOPE-RELATED LIMITATIONS 57
2.8 RISK ASSESSMENT 57
2.9 RECESSION IMPACT ANALYSIS 57
3 EXECUTIVE SUMMARY 58
4 PREMIUM INSIGHTS 62
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN HEALTHCARE SIMULATION MARKET 62
4.2 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE AND COUNTRY 63
4.3 HEALTHCARE SIMULATION MARKET: REGIONAL GROWTH OPPORTUNITIES 64
4.4 REGIONAL MIX: HEALTHCARE SIMULATION MARKET 65
4.5 HEALTHCARE SIMULATION MARKET: EMERGING VS. DEVELOPED ECONOMIES 66
5 MARKET OVERVIEW 67
5.1 INTRODUCTION 67
5.2 MARKET DYNAMICS 67
5.3 MARKET DYNAMICS: IMPACT ANALYSIS 68
5.3.1 DRIVERS 68
- 5.3.1.1 Limited access to patients during medical training 68
- 5.3.1.2 Rising technological advancements in medical education 69
- 5.3.1.3 Growing demand for minimally invasive treatments 69
- 5.3.1.4 Increasing focus on patient safety 70
- 5.3.1.5 Growing preference for virtual interaction 71
5.3.2 RESTRAINTS 71
- 5.3.2.1 Limited availability of funds 71
- 5.3.2.2 Poorly designed medical simulators 71
5.3.3 OPPORTUNITIES 72
- 5.3.3.1 Shortage of healthcare personnel 72
- 5.3.3.2 Growing awareness about simulation training in emerging economies 72
5.3.4 CHALLENGES 73
- 5.3.4.1 High cost of simulators 73
- 5.3.4.2 Operational challenges 73
5.4 INDUSTRY TRENDS 74
5.4.1 USE OF VIRTUAL REALITY AND AUGMENTED REALITY IN HEALTHCARE SIMULATION 74
5.4.2 HIGH-FIDELITY TECHNOLOGICAL ADVANCEMENTS 74
5.4.3 MULTIMODAL APPROACH IN DEVELOPMENT OF SIMULATORS 75
5.4.4 UTILIZATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING SOFTWARE IN SURGICAL PROCEDURES 75
5.4.5 GROWING USE OF HCIT/EMR 76
5.5 TECHNOLOGY ANALYSIS 76
5.5.1 INTEGRATION OF ARTIFICIAL INTELLIGENCE AND VIRTUAL REALITY 77
5.6 ECOSYSTEM ANALYSIS 77
5.7 VALUE CHAIN ANALYSIS 78
5.8 PORTER’S FIVE FORCES ANALYSIS 79
5.8.1 THREAT OF NEW ENTRANTS 80
5.8.2 THREAT OF SUBSTITUTES 80
5.8.3 BARGAINING POWER OF SUPPLIERS 80
5.8.4 BARGAINING POWER OF BUYERS 80
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 81
5.9 PATENT ANALYSIS 81
5.9.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE SIMULATION MARKET 81
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 82
5.9.3 LIST OF MAJOR PATENTS 83
5.10 TARIFF AND REGULATORY LANDSCAPE 85
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
5.10.2 HEALTHCARE SIMULATION PRODUCTS 88
- 5.10.2.1 North America 88
- 5.10.2.1.1 US 88
- 5.10.2.1.2 Canada 89
- 5.10.2.2 Europe 89
- 5.10.2.3 Asia Pacific 89
- 5.10.2.3.1 Japan 89
- 5.10.2.3.2 China 90
- 5.10.2.3.3 India 91
- 5.10.2.1 North America 88
5.10.3 INTEROPERABILITY STANDARDS 91
5.11 PRICING ANALYSIS 94
5.11.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 94
5.11.2 REGIONAL PRICING ANALYSIS OF MEDICAL SIMULATORS 95
5.12 HEALTHCARE SIMULATION MARKET INVESTMENT LANDSCAPE 95
5.13 KEY CONFERENCES AND EVENTS (Q4 2023-Q3 2024) 96
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 97
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 98
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 98
5.15.2 BUYING CRITERIA 99
5.16 CASE STUDY ANALYSIS 100
5.16.1 CASE STUDY 1 100
5.16.2 CASE STUDY 2 101
5.17 UNMET NEEDS 101
5.17.1 END USER EXPECTATIONS 102
6 HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE 104
6.1 INTRODUCTION 105
6.2 HEALTHCARE SIMULATION ANATOMICAL MODELS 105
6.2.1 PATIENT SIMULATORS 107
- 6.2.1.1 By type 111
- 6.2.1.1.1 High-fidelity simulators 111
- 6.2.1.1.1.1 Growing adoption of high-fidelity simulators in educational training to drive growth 111
- 6.2.1.1.2 Medium-fidelity simulators 113
- 6.2.1.1.2.1 Cost benefits of medium-fidelity simulation to drive demand 113
- 6.2.1.1.3 Low-fidelity simulators 114
- 6.2.1.1.3.1 Budgetary constraints and ease of use to drive demand 114
- 6.2.1.1.1 High-fidelity simulators 111
- 6.2.1.2 By application 116
- 6.2.1.2.1 Laparoscopic surgical simulators 116
- 6.2.1.2.1.1 Increasing prevalence of minimally invasive surgeries to drive growth 116
- 6.2.1.2.2 Gynecology simulators 117
- 6.2.1.2.2.1 Increasing incidence of fibroids and polyps in women to drive demand 117
- 6.2.1.2.3 Cardiovascular simulators 118
- 6.2.1.2.3.1 Increasing prevalence of diabetes to boost demand 118
- 6.2.1.2.4 Orthopedic surgical simulators 119
- 6.2.1.2.4.1 Enhancement in surgeon skills by orthopedic simulation training to drive demand 119
- 6.2.1.2.5 Spine surgical simulators 120
- 6.2.1.2.5.1 Mastering spine surgeries through advanced simulation techniques to boost demand 120
- 6.2.1.2.6 Endovascular simulators 121
- 6.2.1.2.6.1 Reduced mortality rates associated with endovascular simulators to boost demand 121
- 6.2.1.2.7 Other applications in patient simulators 122
- 6.2.1.2.1 Laparoscopic surgical simulators 116
- 6.2.1.1 By type 111
6.2.2 TASK TRAINERS 123
- 6.2.2.1 Inability to imitate emotional attributes of patients to restrain growth 123
6.2.3 INTERVENTIONAL/SURGICAL SIMULATORS 125
- 6.2.3.1 Laparoscopic surgical simulators 127
- 6.2.3.1.1 Increasing preference for minimally invasive surgeries to drive growth 127
- 6.2.3.2 Gynecology simulators 129
- 6.2.3.2.1 Increasing incidence of fibroids and polyps in women to drive demand for gynecology simulators 129
- 6.2.3.3 Cardiovascular simulators 130
- 6.2.3.3.1 Increasing prevalence of obesity and diabetes to boost demand 130
- 6.2.3.4 Orthopedic surgical simulators 132
- 6.2.3.4.1 Enhancement in surgeon skills by orthopedic simulation training to drive demand 132
- 6.2.3.5 Spine surgical simulators 133
- 6.2.3.5.1 Mastering spine surgeries through advanced simulation techniques to boost demand 133
- 6.2.3.6 Endovascular simulators 135
- 6.2.3.6.1 Ability to reduce mortality rates to drive demand for endovascular simulators 135
- 6.2.3.7 Other surgical simulators 136
- 6.2.3.1 Laparoscopic surgical simulators 127
6.2.4 ULTRASOUND SIMULATORS 138
- 6.2.4.1 Inferior quality images due to low dynamics and spatial resolution to restrain growth 138
6.2.5 DENTAL SIMULATORS 140
- 6.2.5.1 Expanding dental tourism industry to drive growth 140
6.2.6 EYE SIMULATORS 141
- 6.2.6.1 Increasing incidence of eye disorders to drive growth 141
6.3 WEB-BASED SIMULATION 143
6.3.1 RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF WEB-BASED SIMULATION 143
6.4 HEALTHCARE SIMULATION SOFTWARE 144
6.4.1 KEY ADVANTAGES OFFERED BY HEALTHCARE SIMULATION SOFTWARE TO DRIVE ADOPTION 144
6.5 HEALTHCARE SIMULATION TRAINING SERVICES 146
6.5.1 VENDOR-BASED TRAINING 148
- 6.5.1.1 High focus on patient safety to drive demand 148
6.5.2 EDUCATIONAL SOCIETIES 149
- 6.5.2.1 Growing need for proper training and authenticity of knowledge to drive growth 149
6.5.3 CUSTOM CONSULTING SERVICES 151
- 6.5.3.1 Growing need to limit errors associated with traditional medical training systems to drive growth 151
7 HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY 153
7.1 INTRODUCTION 154
7.2 VIRTUAL PATIENT SIMULATION 154
7.2.1 INCREASING FOCUS ON AUGMENTED REALITY/VIRTUAL REALITY TO DRIVE MARKET 154
7.3 3D PRINTING 155
7.3.1 INCREASING ADOPTION IN MEDICAL TRAINING TO DRIVE MARKET 155
7.4 PROCEDURAL REHEARSAL TECHNOLOGY 156
7.4.1 IMPROVING SURGICAL SKILLS WITH PROCEDURAL REHEARSAL TECHNOLOGY TO DRIVE MARKET 156
8 HEALTHCARE SIMULATION MARKET, BY END USER 158
8.1 INTRODUCTION 159
8.2 ACADEMIC INSTITUTES 159
8.2.1 GROWING NEED FOR SKILLED MEDICAL PROFESSIONALS TO DRIVE DEMAND 159
8.3 HOSPITALS 160
8.3.1 RISING FOCUS ON MINIMIZING MEDICAL ERRORS TO DRIVE DEMAND 160
8.4 MILITARY ORGANIZATIONS 162
8.4.1 EXPLORATION OF NEW METHODS OF MEDICAL CARE DURING WARFARE TO DRIVE DEMAND 162
8.5 OTHER END USERS 163
9 HEALTHCARE SIMULATION MARKET, BY REGION 165
9.1 INTRODUCTION 166
9.2 NORTH AMERICA 166
9.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS 171
9.2.2 US 172
- 9.2.2.1 Increasing demand for virtual tutors and high healthcare spending to boost growth 172
9.2.3 CANADA 175
- 9.2.3.1 Increasing funding and surgical capabilities to drive growth 175
9.3 EUROPE 179
9.3.1 EUROPE: RECESSION IMPACT ANALYSIS 184
9.3.2 UK 184
- 9.3.2.1 Rising number of healthcare simulation centers and hospitals to drive growth 184
9.3.3 FRANCE 188
- 9.3.3.1 Growing focus on use of innovative methods in medical training to drive growth 188
9.3.4 GERMANY 192
- 9.3.4.1 High healthcare spending to drive growth 192
9.3.5 ITALY 196
- 9.3.5.1 Shortage of trained healthcare personnel to drive growth 196
9.3.6 SPAIN 200
- 9.3.6.1 Increasing number of surgical procedures to boost growth 200
9.3.7 REST OF EUROPE 204
9.4 ASIA PACIFIC 208
9.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS 214
9.4.2 JAPAN 214
- 9.4.2.1 Increasing demand for virtual tutors and technologically advanced simulators to drive growth 214
9.4.3 CHINA 218
- 9.4.3.1 Increasing demand for trained medical professionals to drive growth 218
9.4.4 INDIA 221
- 9.4.4.1 Growing awareness regarding patient safety due to healthcare negligence to drive growth 221
9.4.5 REST OF ASIA PACIFIC 225
9.5 LATIN AMERICA 229
9.5.1 LATIN AMERICA: RECESSION IMPACT ANALYSIS 234
9.5.2 BRAZIL 234
- 9.5.2.1 High incidence of chronic diseases to drive market 234
9.5.3 MEXICO 238
- 9.5.3.1 Disruptive technologies and public-private partnerships to boost growth 238
9.5.4 REST OF LATIN AMERICA 242
9.6 MIDDLE EAST & AFRICA 245
9.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT ANALYSIS 250
9.6.2 GCC 250
- 9.6.2.1 Focus on enhancing patient care to drive market 250
9.6.3 REST OF MIDDLE EAST & AFRICA 254
10 COMPETITIVE LANDSCAPE 258
10.1 INTRODUCTION 258
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 258
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS, 2022 260
10.4 MARKET SHARE ANALYSIS 261
10.5 MARKET RANKING ANALYSIS 262
10.6 BRAND/PRODUCT COMPARATIVE ANALYSIS 263
10.6.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT & SERVICE 264
- 10.6.1.1 Laerdal Medical 264
- 10.6.1.2 CAE Inc 264
- 10.6.1.3 Simulab 264
10.6.2 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY TECHNOLOGY PROVIDER COMPANY 265
- 10.6.2.1 Siemens Healthineers AG 265
- 10.6.2.2 Veradigm 265
- 10.6.2.3 Koninklijke Philips N.V 266
10.7 COMPANY EVALUATION MATRIX 266
10.7.1 STARS 266
10.7.2 EMERGING LEADERS 266
10.7.3 PERVASIVE PLAYERS 267
10.7.4 PARTICIPANTS 267
10.7.5 COMPANY FOOTPRINT ANALYSIS 268
10.8 STARTUP/SME EVALUATION MATRIX 271
10.8.1 PROGRESSIVE COMPANIES 271
10.8.2 RESPONSIVE COMPANIES 271
10.8.3 DYNAMIC COMPANIES 271
10.8.4 STARTING BLOCKS 271
10.8.5 COMPETITIVE BENCHMARKING 273
10.9 COMPETITIVE SCENARIO 275
10.9.1 PRODUCT LAUNCHES 275
10.9.2 DEALS 275
10.9.3 OTHER DEVELOPMENTS 276
11 COMPANY PROFILES 277
11.1 KEY PLAYERS 277
11.1.1 CAE INC 277
11.1.2 LAERDAL MEDICAL 282
11.1.3 GAUMARD SCIENTIFIC CO 288
11.1.4 KYOTO KAGAKU 299
11.1.5 LIMBS & THINGS 306
11.1.6 MENTICE AB 311
11.1.7 SIMULAB CORPORATION 316
11.1.8 SIMULAIDS 324
11.1.9 INTELLIGENT ULTRASOUND GROUP PLC 332
11.1.10 OPERATIVE EXPERIENCE INC 336
11.1.11 SURGICAL SCIENCE SWEDEN AB 338
11.1.12 CARDIONICS INC. (SUBSIDIARY OF 3B SCIENTIFIC) 341
11.1.13 VIRTAMED AG 342
11.1.14 SYNBONE AG 344
11.1.15 INGMAR MEDICAL 346
11.1.16 MEDICAL-X 348
11.1.17 KAVO DENTAL GMBH 351
11.1.18 ALTAY SCIENTIFIC 352
11.1.19 TRUCORP LTD 357
11.1.20 SIMENDO B.V 359
11.2 OTHER PLAYERS 360
11.2.1 HAAG-STREIT SIMULATION GMBH 360
11.2.2 SYMGERY 360
11.2.3 HRV SIMULATION 361
11.2.4 SYNAPTIVE MEDICAL 361
11.2.5 INOVUS MEDICAL 362
12 APPENDIX 363
12.1 DISCUSSION GUIDE 363
12.2 CUSTOMIZATION OPTIONS 369
12.3 RELATED REPORTS 369
12.4 AUTHOR DETAILS 370